Fishing for new antimicrobials

Current Opinion in Chemical Biology

Volumn 10, Issue 4, 2006, Pages 327-333

  Mukhopadhyay, Arpita ^a   Peterson, Randall T ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PENICILLIN G; SULFANILAMIDE DERIVATIVE;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; HIGH THROUGHPUT SCREENING; HOST PATHOGEN INTERACTION; IMMUNE SYSTEM; MOLECULAR DYNAMICS; NONHUMAN; REVIEW; RISK ASSESSMENT; ZEBRA FISH;

ANIMALS; ANTI-INFECTIVE AGENTS; COMMUNICABLE DISEASES; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ZEBRAFISH;

DANIO RERIO;

EID: 33746091291     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2006.06.026     Document Type: Review

References (58)

1. Spellberg B., Powers J.H., Brass E.P., Miller L.G., and Edwards Jr. J.E. Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 38 (2004) 1279-1286
2. Gootz T.D. Discovery and development of new antimicrobial agents. Clin Microbiol Rev 3 (1990) 13-31
3. Rosamond J., and Allsop A. Harnessing the power of the genome in the search for new antibiotics. Science 287 (2000) 1973-1976
4. Waller A.S., and Clements J.M. Novel approaches to antimicrobial therapy: peptide deformylase. Curr Opin Drug Discov Devel 5 (2002) 785-792. Bacterial peptide deformylase (PDF) is one of the best and few examples of mechanism-based rational drug design. Because it is absent in humans and required for bacterial survival, PDF is a promising antimicrobial target, and already a few PDF inhibitors have entered clinical trials.
5. Ramakrishnan L., Federspiel N.A., and Falkow S. Granuloma-specific expression of mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 288 (2000) 1436-1439
6. Berthet F.X., Lagranderie M., Gounon P., Laurent-Winter C., Ensergueix D., Chavarot P., Thouron F., Maranghi E., Pelicic V., Portnoi D., et al. Attenuation of virulence by disruption of the mycobacterium tuberculosis erp gene. Science 282 (1998) 759-762
7. Domagk G. A report on the chemotherapy of bacterial infections. Deut Med Woch lxi (1935) 250
8. Trefouel J., Nitti F., and Bovet D. Activity of p-aminophenylsulfamide in the experimental streptococcal infections of the mouse and rabbit. CR Seances Soc Biol 120 (1935) 756
9. In: Ehrlich P. (Ed). Gesammelte Arbeiten (1957), Springer-Verlag
10. Robson J.M., and Keele C.A. Recent Advances in Pharmacology (1956), J&A Churchill
11. Dionne M.S., Ghori N., and Schneider D.S. Drosophila melanogaster is a genetically tractable model host for Mycobacterium marinum. Infect Immun 71 (2003) 3540-3550
12. Mansfield B.E., Dionne M.S., Schneider D.S., and Freitag N.E. Exploration of host-pathogen interactions using Listeria monocytogenes and Drosophila melanogaster. Cell Microbiol 5 (2003) 901-911
13. Lemaitre B., Reichhart J.M., and Hoffmann J.A. Drosophila host defense: differential induction of antimicrobial peptide genes after infection by various classes of microorganisms. Proc Natl Acad Sci USA 94 (1997) 14614-14619
14. Mahajan-Miklos S., Tan M.W., Rahme L.G., and Ausubel F.M. Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model. Cell 96 (1999) 47-56
15. Tan M.W., Mahajan-Miklos S., and Ausubel F.M. Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc Natl Acad Sci USA 96 (1999) 715-720
16. Rahme L.G., Stevens E.J., Wolfort S.F., Shao J., Tompkins R.G., and Ausubel F.M. Common virulence factors for bacterial pathogenicity in plants and animals. Science 268 (1995) 1899-1902
17. Rahme L.G., Tan M.W., Le L., Wong S.M., Tompkins R.G., Calderwood S.B., and Ausubel F.M. Use of model plant hosts to identify Pseudomonas aeruginosa virulence factors. Proc Natl Acad Sci USA 94 (1997) 13245-13250
18. Ewbank J.J. Tackling both sides of the host-pathogen equation with Caenorhabditis elegans. Microbes Infect 4 (2002) 247-256
19. Hoffmann J.A. The immune response of drosophila. Nature 426 (2003) 33-38
20. Kurz C.L., and Ewbank J.J. Caenorhabditis elegans: an emerging genetic model for the study of innate immunity. Nat Rev Genet 4 (2003) 380-390
21. Long Q., Meng A., Wang H., Jessen J.R., Farrell M.J., and Lin S. GATA-1 expression pattern can be recapitulated in living transgenic zebrafish using GFP reporter gene. Development 124 (1997) 4105-4111
22. Broadbent J., and Read E.M. Wholemount in situ hybridization of xenopus and zebrafish embryos. Methods Mol Biol 127 (1999) 57-67
23. Macdonald R. Zebrafish immunohistochemistry. Methods Mol Biol 127 (1999) 77-88
24. Nasevicius A., and Ekker S.C. Effective targeted gene 'knockdown' in zebrafish. Nat Genet 26 (2000) 216-220
25. Trede N.S., Langenau D.M., Traver D., Look A.T., and Zon L.I. The use of zebrafish to understand immunity. Immunity 20 (2004) 367-379
26. Boshra H., Li J., and Sunyer J.O. Recent advances on the complement system of teleost fish. Fish Shellfish Immunol 20 (2006) 239-262
27. •]) demonstrated the presence of Toll-like receptors (TLRs) in zebrafish and their homology to human TLRs, validating the use of zebrafish as a model to study innate immunity.
28. •].
29. Lieschke G.J., Oates A.C., Crowhurst M.O., Ward A.C., and Layton J.E. Morphologic and functional characterization of granulocytes and macrophages in embryonic and adult zebrafish. Blood 98 (2001) 3087-3096
30. Herbomel P., Thisse B., and Thisse C. Ontogeny and behaviour of early macrophages in the zebrafish embryo. Development 126 (1999) 3735-3745
31. Willett C.E., Cherry J.J., and Steiner L.A. Characterization and expression of the recombination activating genes (rag1 and rag2) of zebrafish. Immunogenetics 45 (1997) 394-404
32. Danilova N., Bussmann J., Jekosch K., and Steiner L.A. The immunoglobulin heavy-chain locus in zebrafish: identification and expression of a previously unknown isotype, immunoglobulin Z. Nat Immunol 6 (2005) 295-302. This paper reports the identification of a new immunoglobin subtype in zebrafish which does not have a counterpart in humans, cautioning us against straightforward extrapolation of insights from zebrafish immune system studies to human immunity.
33. Cannon J.P., Haire R.N., Rast J.P., and Litman G.W. The phylogenetic origins of the antigen-binding receptors and somatic diversification mechanisms. Immunol Rev 200 (2004) 12-22
34. Phelps H.A., and Neely M.N. Evolution of the zebrafish model: from development to immunity and infectious disease. Zebrafish 2 (2005) 87-103
35. van der Sar A.M., Appelmelk B.J., Vandenbroucke-Grauls C.M., and Bitter W. A star with stripes: zebrafish as an infection model. Trends Microbiol 12 (2004) 451-457
36. LaPatra S.E., Barone L., Jones G.R., and Zon L.I. Effects of infectious hematopoietic necrosis virus and infectious pancreatic necrosis virus infection on hematopoietic precursors of the zebrafish. Blood Cells Mol Dis 26 (2000) 445-452
37. Garner J.N., Joshi B., and Jagus R. Characterization of rainbow trout and zebrafish eukaryotic initiation factor 2alpha and its response to endoplasmic reticulum stress and IPNV infection. Dev Comp Immunol 27 (2003) 217-231
38. Sanders G.E., Batts W.N., and Winton J.R. Susceptibility of zebrafish (Danio rerio) to a model pathogen, spring viremia of carp virus. Comp Med 53 (2003) 514-521
39. Phelan P.E., Pressley M.E., Witten P.E., Mellon M.T., Blake S., and Kim C.H. Characterization of snakehead rhabdovirus infection in zebrafish (Danio rerio). J Virol 79 (2005) 1842-1852
40. Linell F., and Norden A. Skin infection caused by a new type of Mycobacterium in swimming pools. Nord Med 47 (1952) 888-891
41. Tonjum T., Welty D.B., Jantzen E., and Small P.L. Differentiation of Mycobacterium ulcerans, M. marinum, and M. haemophilum: mapping of their relationships to M. tuberculosis by fatty acid profile analysis, DNA-DNA hybridization, and 16S rRNA gene sequence analysis. J Clin Microbiol 36 (1998) 918-925
42. Prouty M.G., Correa N.E., Barker L.P., Jagadeeswaran P., and Klose K.E. Zebrafish-Mycobacterium marinum model for mycobacterial pathogenesis. FEMS Microbiol Lett 225 (2003) 177-182
43. van der Sar A.M., Abdallah A.M., Sparrius M., Reinders E., Vandenbroucke-Grauls C.M., and Bitter W. Mycobacterium marinum strains can be divided into two distinct types based on genetic diversity and virulence. Infect Immun 72 (2004) 6306-6312
44. Davis J.M., Clay H., Lewis J.L., Ghori N., Herbomel P., and Ramakrishnan L. Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 17 (2002) 693-702. First use of zebrafish for real-time analysis of a pathogen infecting a vertebrate host.
45. Meijer A.H., Verbeek F.J., Salas-Vidal E., Corredor-Adamez M., Bussman J., van der Sar A.M., Otto G.W., Geisler R., and Spaink H.P. Transcriptome profiling of adult zebrafish at the late stage of chronic tuberculosis due to Mycobacterium marinum infection. Mol Immunol 42 (2005) 1185-1203. This report describes large-scale transcriptome analysis of gene expression changes on chronic mycobacterial-infection of zebrafish leading to new insights into mycobacterial pathogenesis.
46. Menudier A., Rougier F.P., and Bosgiraud C. Comparative virulence between different strains of listeria in zebrafish (Brachydanio rerio) and mice. Pathol Biol (Paris) 44 (1996) 783-789
47. Neely M.N., Pfeifer J.D., and Caparon M. Streptococcus-zebrafish model of bacterial pathogenesis. Infect Immun 70 (2002) 3904-3914
48. Lau G.W., Haataja S., Lonetto M., Kensit S.E., Marra A., Bryant A.P., McDevitt D., Morrison D.A., and Holden D.W. A functional genomic analysis of type 3 Streptococcus pneumoniae virulence. Mol Microbiol 40 (2001) 555-571
49. Miller J.D., and Neely M.N. Large-scale screen highlights the importance of capsule for virulence in the zoonotic pathogen Streptococcus iniae. Infect Immun 73 (2005) 921-934. First large-scale attempt to identify host genes involved in zebrafish infection by Streptococcus iniae. This report provides proof of principle for use of zebrafish infection models in identification of host pathogenesis factors.
50. Brenot A., King K.Y., Janowiak B., Griffith O., and Caparon M.G. Contribution of glutathione peroxidase to the virulence of Streptococcus pyogenes. Infect Immun 72 (2004) 408-413
51. Peterson R.T., Link B.A., Dowling J.E., and Schreiber S.L. Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc Natl Acad Sci USA 97 (2000) 12965-12969
52. Moon H.S., Jacobson E.M., Khersonsky S.M., Luzung M.R., Walsh D.P., Xiong W., Lee J.W., Parikh P.B., Lam J.C., Kang T.W., et al. A novel microtubule destabilizing entity from orthogonal synthesis of triazine library and zebrafish embryo screening. J Am Chem Soc 124 (2002) 11608-11609
53. Khersonsky S.M., Jung D.W., Kang T.W., Walsh D.P., Moon H.S., Jo H., Jacobson E.M., Shetty V., Neubert T.A., and Chang Y.T. Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. J Am Chem Soc 125 (2003) 11804-11805
54. Peterson R.T., Shaw S.Y., Peterson T.A., Milan D.J., Zhong T.P., Schreiber S.L., MacRae C.A., and Fishman M.C. Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat Biotechnol 22 (2004) 595-599
55. Stern H.M., Murphey R.D., Shepard J.L., Amatruda J.F., Straub C.T., Pfaff K.L., Weber G., Tallarico J.A., King R.W., and Zon L.I. Small molecules that delay S phase suppress a zebrafish bmyb mutant. Nat Chem Biol 1 (2005) 366-370
56. Hill A.J., Teraoka H., Heideman W., and Peterson R.E. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 86 (2005) 6-19
57. Zon L.I., and Peterson R.T. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 4 (2005) 35-44
58. Spitsbergen J.M., and Kent M.L. The state of the art of the zebrafish model for toxicology and toxicologic pathology research-advantages and current limitations. Toxicol Pathol 31 (2003) 62-87